MedinCell S.A. (MDCLF)
USD 6.98
(0.0%)
USD 6.98
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 9.16 Million EUR | -7.88% |
| 2023 | 9.94 Million EUR | 143.13% |
| 2022 | 4.09 Million EUR | -39.27% |
| 2021 | 6.73 Million EUR | 257.67% |
| 2020 | 1.88 Million EUR | 333.87% |
| 2019 | 434 Thousand EUR | -93.02% |
| 2018 | 6.22 Million EUR | -18.67% |
| 2017 | 7.64 Million EUR | -3.19% |
| 2016 | 7.9 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 4.09 Million EUR | 0.0% |
| 2024 Q1 | 4.09 Million EUR | 37.57% |
| 2024 Q3 | 1.88 Million EUR | -53.97% |
| 2024 FY | 9.16 Million EUR | -7.88% |
| 2024 Q4 | 1.71 Million EUR | -8.74% |
| 2023 Q2 | 3.85 Million EUR | 0.0% |
| 2023 Q4 | 2.97 Million EUR | 0.0% |
| 2023 Q1 | 3.85 Million EUR | 81.0% |
| 2023 FY | 9.94 Million EUR | 143.13% |
| 2023 Q3 | 2.97 Million EUR | -22.87% |
| 2022 Q1 | 2.03 Million EUR | -19.07% |
| 2022 FY | 4.09 Million EUR | -39.27% |
| 2022 Q4 | 2.12 Million EUR | 0.0% |
| 2022 Q3 | 2.12 Million EUR | 4.41% |
| 2022 Q2 | 2.03 Million EUR | 0.0% |
| 2021 Q1 | 1.57 Million EUR | 50.45% |
| 2021 Q4 | 2.52 Million EUR | 0.0% |
| 2021 Q3 | 2.52 Million EUR | 60.2% |
| 2021 Q2 | 1.57 Million EUR | 0.0% |
| 2021 FY | 6.73 Million EUR | 257.67% |
| 2020 FY | 1.88 Million EUR | 333.87% |
| 2020 Q2 | 1.95 Million EUR | 0.0% |
| 2020 Q3 | 1.04 Million EUR | -46.51% |
| 2020 Q4 | 1.04 Million EUR | 0.0% |
| 2020 Q1 | 1.95 Million EUR | 74.12% |
| 2019 Q3 | 1.12 Million EUR | 30.3% |
| 2019 FY | 434 Thousand EUR | -93.02% |
| 2019 Q2 | 861.5 Thousand EUR | 0.0% |
| 2019 Q1 | 861.5 Thousand EUR | -68.14% |
| 2019 Q4 | 1.12 Million EUR | 0.0% |
| 2018 Q3 | 2.7 Million EUR | 102.17% |
| 2018 Q4 | 2.7 Million EUR | 0.0% |
| 2018 FY | 6.22 Million EUR | -18.67% |
| 2018 Q1 | 1.33 Million EUR | 0.0% |
| 2018 Q2 | 1.33 Million EUR | 0.0% |
| 2017 FY | 7.64 Million EUR | -3.19% |
| 2016 FY | 7.9 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | 38.929% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | -295193.359% |
| SQZ Biotechnologies Company | 9.79 Million USD | 6.473% |
| Evofem Biosciences, Inc. | 11.7 Million USD | 21.75% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 92.309% |
| Mesoblast Limited | -35.16 Million USD | 126.046% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | 26922.84% |
| Genus plc | 178.7 Million USD | 94.874% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -2133.248% |
| Marizyme, Inc. | 457.7 Thousand USD | -1901.302% |
| ContraFect Corporation | -154 Thousand USD | 6048.052% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | 83372.727% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | 18420.0% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -11833.143% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -13836.222% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 2463.865% |
| MultiCell Technologies, Inc. | 49.32 USD | -18572487.186% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | 77.251% |
| EV Biologics, Inc. | 48.9 Thousand USD | -18632.106% |
| Q BioMed Inc. | -8988.00 USD | 102013.663% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | 67.581% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | 59487.967% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 220.1 Million USD | 95.838% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -12985.714% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 7472.174% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | -14620.535% |
| THC Farmaceuticals, Inc. | -4952.00 USD | 185075.767% |
| Arch Therapeutics, Inc. | -2439.00 USD | 375663.756% |
| IMV Inc. | -962.29 Thousand USD | 1051.888% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | -6419.573% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 9493.427% |
| GB Sciences, Inc. | -624.00 USD | 1468048.718% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 10747.696% |
| HST Global, Inc. | - USD | -Infinity% |
| CSL Limited | 7.56 Billion USD | 99.879% |
| Halberd Corporation | -208.00 USD | 4403946.154% |
| Enzolytics Inc. | 30.7 Thousand USD | -29729.36% |
| Resverlogix Corp. | - USD | -Infinity% |
| Affymax, Inc. | 1.35 Million USD | -574.947% |
| SYBLEU INC | 11.69 Thousand USD | -78217.373% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | -1798.709% |
| argenx SE | 1.1 Billion USD | 99.174% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 135.507% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -1383.68% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 97.763% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | 103532.701% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | 79.35% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 902.402% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | -827.143% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 9.61 Million USD | 4.693% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | 11024.4% |
| BioStem Technologies, Inc. | 15.42 Million USD | 40.615% |
| ONE Bio Corp. | 20.12 Million USD | 54.485% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Agentix Corp. | - USD | -Infinity% |
| LadRx Corporation | -11.83 Thousand USD | 77497.55% |
| Cell Source, Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | 19080.915% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -5088.038% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -5088.038% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 1880.335% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | -630.13 Thousand USD | 1553.65% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| CytoDyn Inc. | -29 Thousand USD | 31686.207% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | -1935.361% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 2966.917% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | -98.785% |
| Bioxytran, Inc. | -8285.00 USD | 110661.255% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | - USD | -Infinity% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 2555.764% |
| Neutra Corp. | 14.33 Thousand USD | -63799.547% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 11270.732% |
| PureTech Health plc | -1.6 Million USD | 671.429% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 1014.869% |
| IXICO plc | 3.27 Million USD | -180.122% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 1419.885% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 611.446% |
| CSL Limited | 7.7 Billion USD | 99.881% |
| Cellectis S.A. | 18 Thousand USD | -50788.889% |